Most of Torrent Pharma's 51% sales growth came from buying J.B.
Torrent Pharma's sales in July to September 2025 and 2026, in ₹ crore. J.B. brought ₹1,086 crore of the ₹1,677 crore rise.
Most of Torrent Pharma's 51% sales growth came from buying J.B.
Torrent Pharma's sales in July to September 2025 and 2026, in ₹ crore. J.B. brought ₹1,086 crore of the ₹1,677 crore rise.
₹ CRORE, REVENUE FROM OPERATIONS
Torrent's own businessJ.B. business
J.B. is in Torrent's accounts from 21 January 2026. Torrent's own business grew 18%.
Torrent Pharmaceuticals, consolidated results and press release, BSE filing of 23 October 2026 · Jul to Sep 2025 and 2026
Share it
The numbers
Embed it on your site
The code carries a credit line that links back to this page. Keep it with the chart.
From the insight
Sources
- Torrent results, 23 October 2026, page 16: consolidated revenue from operations, 3,302 for the quarter ended 30 September 2025, before J.B.
- Torrent press release, 23 October 2026, page 25: Q2 FY27 revenue, base business 3,893 and JB business 1,086, total 4,979
- Torrent press release, 23 October 2026, page 24: base revenues at Rs. 3,893 crores were up 18%